Burkitt post-transplantation lymphoma in adult solid organ transplant recipients

Plasmablastic Posttransplant Lymphoma

(2012) Heiner Zimmermann et al.   TRANSPLANTATION

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

(2011) R. Reshef et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

(2011) J. A. Barnes et al.   ANNALS OF ONCOLOGY

Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder

(2011) Jennifer Picarsic et al.   CANCER

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

(2011) R. Trappe et al.   HAEMATOLOGICA

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

(2011) Ralf Trappe et al.   LANCET ONCOLOGY

Advances in the understanding of MYC-induced lymphomagenesis

(2010) Kay Klapproth et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

(2010) Sharon Barrans et al.   JOURNAL OF CLINICAL ONCOLOGY

High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma

(2008) Albert Oriol et al.   CANCER

Burkitt Lymphoma in Adults

(2008) A. S. Perkins et al.   Hematology-American Society of Hematology Education Program